Can-Fite BioPharma Ltd. logo
Can-Fite BioPharma Ltd. CANF
$ 0.29 -5.01%

Annual report 2024
added 11-29-2025

report update icon

Can-Fite BioPharma Ltd. Gross Profit 2011-2025 | CANF

Gross profit is a key indicator of how efficiently a company produces or sells its products. This metric helps assess a business’s ability to generate revenue at the initial stage, before accounting for all other expenses. Regular analysis of gross profit allows companies to respond in a timely manner to changes in cost of goods, pricing strategy, and market conditions.

Calculation formula:
Gross Profit = Revenue – Cost of Goods Sold (COGS)

Revenue — all cash inflows from the sale of goods or services.
Cost of Goods Sold — direct costs related to the production or acquisition of goods:
  • Raw materials and supplies
  • Wages of production personnel
  • Depreciation of equipment
  • Transportation and warehousing costs (if directly related to production)
Importance for business:
  • Assessing core business profitability
    If gross profit is declining, it may indicate rising production costs or falling sales.
  • Financial planning
    Gross profit is the basis for calculating other key metrics, such as operating and net profit.
  • Benchmarking against competitors
    Gross profit analysis helps compare the efficiency of different companies within the same industry.
  • Insights into pricing effectiveness
    If gross profit is low, the company may be pricing too low or failing to control costs effectively.
Reasons for a decline in gross profit:
  • Increase in raw material and supply costs
  • Rising production expenses
  • Price reductions due to competition
  • Decrease in sales volume
  • Currency exchange rate fluctuations (for imports/exports)

Gross profit is an important metric, but it does not provide a complete picture of a company’s financial health, as it does not account for administrative and selling expenses, taxes, debt burden, or depreciation.

Annual Gross Profit Can-Fite BioPharma Ltd.

2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
- - - - - 2.03 M 3.82 M 847 K 170 K 165 K - - - 469 K

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
3.82 M 165 K 1.25 M

Gross Profit of other stocks in the Biotechnology industry

Issuer Gross Profit Price % 24h Market Cap Country
AbbVie AbbVie
ABBV
10.7 B $ 223.01 -0.99 % $ 395 B usaUSA
Arbutus Biopharma Corporation Arbutus Biopharma Corporation
ABUS
-40.6 M $ 4.68 1.85 % $ 777 M canadaCanada
Aclaris Therapeutics Aclaris Therapeutics
ACRS
172 K $ 3.38 3.21 % $ 261 M usaUSA
Acasti Pharma Acasti Pharma
ACST
-32.3 K - 4.01 % $ 150 M canadaCanada
Adaptimmune Therapeutics plc Adaptimmune Therapeutics plc
ADAP
1.12 M - -15.15 % $ 60.3 M britainBritain
Ascendis Pharma A/S Ascendis Pharma A/S
ASND
319 M $ 212.3 5.5 % $ 5 B danmarkDanmark
Alexion Pharmaceuticals, Inc. Alexion Pharmaceuticals, Inc.
ALXN
5.52 B - - $ 40.3 B usaUSA
Albireo Pharma Albireo Pharma
ALBO
39.2 M - -0.23 % $ 916 M usaUSA
Aptorum Group Limited Aptorum Group Limited
APM
-104 K $ 1.33 -1.48 % $ 7.25 M chinaChina
Alterity Therapeutics Limited Alterity Therapeutics Limited
ATHE
177 K $ 3.4 1.49 % $ 8.18 B australiaAustralia
EyeGate Pharmaceuticals, Inc. EyeGate Pharmaceuticals, Inc.
EYEG
12.1 - -1.52 % $ 24.7 M usaUSA
AstraZeneca PLC AstraZeneca PLC
AZN
43.9 B $ 90.34 -1.28 % $ 96.9 B britainBritain
Amphastar Pharmaceuticals Amphastar Pharmaceuticals
AMPH
374 M $ 25.76 0.19 % $ 1.25 B usaUSA
Anika Therapeutics Anika Therapeutics
ANIK
103 M $ 9.53 -1.19 % $ 140 M usaUSA
Aytu BioScience Aytu BioScience
AYTU
45.8 M $ 2.33 2.3 % $ 14.6 M usaUSA
Arena Pharmaceuticals Arena Pharmaceuticals
ARNA
319 K - -6.81 % $ 3.04 B usaUSA
Институт стволовых клеток человека Институт стволовых клеток человека
ISKJ
774 M - - - russiaRussia
Axon Enterprise Axon Enterprise
AXON
1.24 B $ 586.28 3.15 % $ 44.4 B usaUSA
Biogen Biogen
BIIB
12.4 B $ 173.03 -2.55 % $ 25.2 B usaUSA
Brickell Biotech Brickell Biotech
BBI
1.82 K - -5.38 % $ 6.06 M usaUSA
Benitec Biopharma Benitec Biopharma
BNTC
282 K $ 12.91 0.78 % $ 531 M usaUSA
Biohaven Pharmaceutical Holding Company Ltd. Biohaven Pharmaceutical Holding Company Ltd.
BHVN
371 M $ 11.55 8.86 % $ 747 M usaUSA
Enochian Biosciences Enochian Biosciences
ENOB
37.5 K - - $ 40.5 M usaUSA
Catalyst Biosciences Catalyst Biosciences
CBIO
109 M $ 15.32 5.73 % $ 1.01 B usaUSA
Acer Therapeutics Acer Therapeutics
ACER
1.27 M - 2.71 % $ 14 M usaUSA
BeiGene, Ltd. BeiGene, Ltd.
BGNE
3.22 B - 0.49 % $ 251 B cayman-islandsCayman-islands
Cerus Corporation Cerus Corporation
CERS
60.4 M $ 2.14 13.23 % $ 395 M usaUSA
Acorda Therapeutics Acorda Therapeutics
ACOR
119 M - -24.86 % $ 820 K usaUSA
Berkeley Lights Berkeley Lights
BLI
53.8 M - -7.31 % $ 87 M usaUSA
bluebird bio bluebird bio
BLUE
-4.03 M - - $ 546 M usaUSA
Bristol-Myers Squibb Company Bristol-Myers Squibb Company
BMY
18.1 B $ 51.05 -0.32 % $ 103 B usaUSA
Abeona Therapeutics Abeona Therapeutics
ABEO
925 K $ 5.5 0.46 % $ 118 M usaUSA
ADiTx Therapeutics ADiTx Therapeutics
ADTX
-493 K $ 2.36 -7.29 % $ 31.1 K usaUSA
BioXcel Therapeutics BioXcel Therapeutics
BTAI
24.3 $ 2.1 -4.34 % $ 5.32 M usaUSA
Coherus BioSciences Coherus BioSciences
CHRS
339 M $ 1.42 6.77 % $ 134 M usaUSA
BioLineRx Ltd. BioLineRx Ltd.
BLRX
19.7 M $ 3.22 -2.72 % $ 908 M israelIsrael
Celldex Therapeutics Celldex Therapeutics
CLDX
5.48 M $ 28.33 0.5 % $ 1.82 M usaUSA
Advaxis Advaxis
ADXS
90 K - -9.65 % $ 45.9 M usaUSA
Baudax Bio Baudax Bio
BXRX
-1.24 M - 0.59 % $ 63 K usaUSA
Завод ДИОД Завод ДИОД
DIOD
325 M - - - russiaRussia